Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Amicus Therapeutics
Amicus Therapeutics to Present at J.P. Morgan Healthcare Conference
January 9th, 2009
Amicus Therapeutics (NASDAQ:FOLD) announced that its President & CEO John F. Crowley will present a corporate overview and the Company's 2009 key business objectives at the 27th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2009, at 11:30 a.m. PT (2:30 p.m. ET). The conference will be held in San Francisco, California. Mr. Crowley's presentation will include an update regarding the Company's discussions with US and EU regulatory authorities about Phase 3 development of Amigal(TM) (migalastat hydrochloride), an oral therapeutic drug candidate for the treatment of Fabry disease. The Company expects to initiate Phase 3 development of Amigal(TM) in the...
Source: Health Business Week (2009-01-09)
|
